학술논문
Efficacy and Safety of Firibastat, A First-in-Class Brain Aminopeptidase A Inhibitor, in Hypertensive Overweight Patients of Multiple Ethnic Origins: A Phase 2, Open-Label, Multicenter, Dose-Titrating Study
Document Type
Article
Author
Source
In: Circulation . (Circulation, 9 July 2019, 140(2):138-146)
Subject
Language
English
ISSN
15244539
00097322
00097322